Seizure disorders

A seizure is irregular electrical activity in the brain caused by the hyperexcitability of neurons, especially in cortical areas. Hyperexcitability, in turn, is the result of altered cellular electrochemical properties, which may be caused, for example, by electrolyte imbalances. The etiology varies according to age. Seizures may be provoked by acute conditions (e.g., stroke, traumatic brain injury, alcohol withdrawal) or unprovoked, in which case they are indicative of epilepsy. The lifetime risk for experiencing at least one seizure is approx. 3% in the general population. Individuals who experience a single seizure do not necessarily have epilepsy. Seizures may be classified as generalized or focal. Generalized seizures arise from discharges in both hemispheres, whereas focal seizures begin with discharges in one hemisphere. Depending on the origin of the epileptiform discharge and the type of the seizure, various temporary motor, sensory, autonomic, or psychological symptoms may occur. However, the most frequent clinical presentation involves rhythmic twitching and loss of consciousness (tonic-clonic seizure). After a first seizure occurs, the likely cause must be determined based on medical history (evaluation of provocative factors and seizure type), laboratory tests, and imaging (to detect or rule out structural or metabolic causes). Electroencephalography (EEG) is used to establish the diagnosis. Important antiepileptic drugs are lamotrigine (first-line treatment in focal seizures), valproate (first-line treatment in generalized seizures) and ethosuximide (first-line treatment in typical absence seizures). With appropriate pharmacotherapy, the majority of patients remain seizure‑free in the long term. Epileptic seizures can evolve into ongoing seizure activity (status epilepticus), which is a potentially life‑threatening event and must be addressed as soon as possible (pharmacologic interruption of seizures with a benzodiazepine).

Also see the article on generalized epilepsy in childhood.

• Seizure: abnormal, unregulated electrical activity of cortical neurons that results in transient changes in behavior and/or EEG findings
• Epilepsy: a chronic neurologic disorder characterized by any of the following:
  • Two or more unprovoked seizures separated by more than 24 hours
  • One unprovoked seizure with an underlying predisposition to seizures (recurrence risk over the next 10 years that is similar to the recurrence risk after two unprovoked seizures)
  • Diagnosis of an epilepsy syndrome
• Symptomatic epilepsy: : epilepsy due to an identifiable condition (e.g., brain tumor, structural abnormalities of the brain) that causes an increased predisposition to seizures
• Cryptogenic epilepsy: epilepsy due to an unknown cause (genetic association suspected)
• Nonepileptic seizure: seizures that are provoked by acute conditions (e.g., intoxication, metabolic disturbances). See provoked seizure for details.
• Epilepsy syndromes: epileptic disorders defined by a collection of characteristic clinical manifestations and other features (e.g., age of onset, brain lesions)

References:^{[1][2][3][4][5]}

• Prevalence:
  • Infants: ∼ 100/100,000
  • Adults : ∼ 40/100,000
  • The elderly : ∼ 140/100,000
• Risk of experiencing at least one seizure up to the age of 75 (in the general population): ∼ 3%

References:^[6]

Epidemiological data refers to the US, unless otherwise specified.

Epilepsy

• Unprovoked seizure (epileptic seizure): due to a general increase in neuronal hyperexcitability
  • Genetic: genetic mutations of ion channels or transmitter receptors, chromosomal abnormalities
  • Cryptogenic (idiopathic)
  • Structural/metabolic: preexisting, chronic cerebral lesion of CNS abnormality; (e.g., hypoxic-ischemic injury; , PKU; , tuberous sclerosis, congenital cerebral malformations)

Although these seizures are referred to as unprovoked, they may be triggered by certain provocative factors!

Provocative factors for epilepsy

Situational factors that can trigger epileptic seizures in epilepsy patients:

• Excessive physical exertion
• Sleep deprivation
• Strobe light flashing
• Loud music

Provoked seizures

Acute symptomatic seizures that are secondary to acute conditions:

• Metabolic and electrolyte disturbances: : hypoglycemia and hyperglycemia, hyponatremia and hypernatremia, hypocalcemia, uremia, thyroid storm, hyperthermia, water intoxication
• Mass: : brain tumors and metastases, hippocampal sclerosis
• Withdrawal
  • Alcohol withdrawal (most common trigger in adults)
  • Noncompliance with anticonvulsant treatment
  • Medication withdrawal
• Intoxication
  • Acute intoxication: cocaine, ecstasy, carbon monoxide poisoning, metal poisoning
  • Pharmacotherapy: amitriptyline, penicillin, maprotiline, lithium, lidocaine, antipsychotics, theophylline
• Infections: encephalitis, brain abscess, meningitis, septic shock
• Ischemia: : stroke, perinatal injuries
• Trauma: traumatic brain injury
• Increased ICP and cerebral edema: eclampsia, hypertensive encephalopathy, cerebrovascular malformation
• Fever: in infants and children (see febrile seizures)

Withdrawal from ABBA (alcohol, benzodiazepines, barbiturates, antiseizure drugs) can cause seizures!

Common causes according to age group

References:^{[7][8][9][10]}

References:^{[6][7][11][12][13][14][15]}

1. Etiological classification (ILAE 2010)
   • Genetic: without a discernible structural or metabolic cause
   • Structural or metabolic: with a discernible structural or metabolic cause
   • Unknown: no tangible cause (the cause is inferred from the clinical presentation and history)
2. Classification according to anatomical origin and clinical features
   • Focal seizures
     • Focal seizures without dyscognitive features
     • Focal seizures with dyscognitive features
   • Primary generalized seizures
     • Classic tonic‑clonic seizures (see grand mal seizure)
     • Further generalized seizures
       • Absence (see also generalized epilepsies in childhood)
       • Myoclonic (see juvenile myoclonic epilepsy)
       • Clonic seizures
       • Tonic seizures
       • Atonic seizures

References:^[16]

• Ictal phase
  • Sudden onset
  • Rapid progression of symptoms
  • Duration usually 1–3 minutes
• Postictal phase
  • Varying degree of confusion, impaired alertness
  • Residual neurologic symptoms (e.g., Todd's paralysis)
  • Duration usually minutes or hours
• Symptoms of, e.g., CNS infection, stroke, intoxication, hypoglycemia, electrolyte disturbances → indicative of acute symptomatic seizure

Focal seizures

Focal seizures are more likely to be caused by focal structural abnormalities. Symptoms depend on the anatomical location of the lesion or disturbance within the brain.

Primarily generalized seizures

Symptoms are produced by bilateral cerebral cortex disturbances.

Focal seizures may eventually involve both cerebral hemispheres, thereby evolving into a generalized seizure (typically focal frontal lobe seizures!). Distinguishing between pure focal, focal → generalized, and purely generalized seizures is crucial!

References:^{[1][11][15][17][18]}

Confirm a seizure

• Patient history: (from patient or witnesses): e.g., evidence of an aura, observation of typical symptoms (e.g., twitching), identification of provocative factors (e.g., sleep deprivation or unreliable intake of antiseizure medication )
• EEG
  • During the seizure (ictal)
    • Epileptiform discharges (e.g., spikes, sharp waves, spike waves, and hypsarrhythmia) are usually detected.
    • If no epileptiform discharges are detected, diagnosis of pseudoseizures should be considered.
  • Between seizures (interictal)
    • Often normal findings (even after provocation via sleep deprivation, hyperventilation, or visual stimuli)
    • Possibly showing epileptiform activity (bursts of abnormal discharges featuring spikes and/or sharp waves)

Exclude an underlying condition

• ECG: In every patient with loss of consciousness during an ictal event, cardiogenic causes (e.g., cardiac arrhythmias resulting in cerebral hypoxia) should be ruled out.
• CT/MRI (with and without contrast): structural lesions (e.g., brain tumors) should be ruled out after a first seizure.
• Laboratory tests
  • Blood
    • Glucose
    • Electrolytes
    • Prolactin
    • Antiepileptic drug levels
    • Toxicology screen
    • CBC
    • ESR
    • Rapid plasma reagin
    • Creatine kinase
    • Renal and liver function tests
• Lumbar puncture: cerebrospinal fluid analysis (e.g., if CNS infection is suspected)

The first focal seizure or the first focal seizure evolving into a generalized seizure in adults indicates a seizure of structural or metabolic origin and requires further evaluation!

References:^{[4][7][11][12][15]}

• Psychological disorders:
  • Pseudoseizures: not true seizures; paroxysmal events that may clinically resemble epileptic seizures but have a psychiatric origin
  • Panic attacks
  • Psychogenic hyperventilation
• Syncope:
  • Vasovagal syncope
  • Stokes-Adams attack
  • Carotid sinus syndrome
  • Cardiac failure
  • Orthostatic hypotension
• Stroke (including transient ischemic attack )
• Migraine
• Sleep disorders
  • REM sleep behavior disorder
  • Narcolepsy
• Breath-holding spell (benign condition)
  • Occurs in children (6 months–6 years )
  • Strong association with iron deficiency anemia
  • Clinical features
    • Episodes of prolonged expiratory apnea
    • Followed by loss of consciousness (syncope)
    • Transient paroxysms of cyanosis or pallor
    • Possibly generalized stiffness and jerky movements of the limbs (anoxic seizure)
  • Triggers: distress, strong emotions (e.g., anger, frustration) due to tantrums or injury
  • Diagnosis: based on typical presentation of BHS (no confirmatory test exists)
    • Further work-up is generally not necessary. Only if atypical presentation of BHS:
      • EEG to differentiate from epileptic seizures
      • ECG to rule out cardiac causes of syncope
    • Laboratory analysis: CBC, serum ferritin (rule out iron deficiency anemia)
  • Treatment: reassurance

Postictal disorientation is key to differentiating between seizures and syncope. Syncope may be accompanied by twitches; however, patients become completely reoriented after a few seconds!

References:^[11]

The differential diagnoses listed here are not exhaustive.

Acute management

• Cardiopulmonary resuscitation (ABCs)
• Avoid hazards
• Monitor vital signs (especially oxygenation via pulse oximetry)

First seizure

• Long-term medical therapy is usually not required, unless there are abnormalities seen on EEG or MRI (or the patient is in status epilepticus).
• Remove cause or provoking factors (e.g., stop illicit drug abuse, treat underlying disorders).

Recurrent seizures

Medical therapy

• Principles of treatment
  • In epilepsy, the seizure threshold is pathologically lowered → Antiepileptic drugs work by raising this lowered threshold and thus protecting against future seizures.
  • Criteria for the choice of antiepileptic drugs
    • Type of epilepsy (as per clinical evaluation or instrumental findings)
    • Patient age
    • Comorbidities and contraindications
• Indications
  • Recurrent seizures (2 seizures/6 months) of unknown cause or with a cause that can not be eliminated
  • After the first seizure → only if neuroimaging or EEG show specific findings (e.g., hippocampal sclerosis, characteristic spike‑wave patterns)
• Treatment options

• Combination therapy
  • If possible, monotherapy should be maintained → increase dosage before initiating combination therapy
  • If combination therapy is administered, drugs from different classes and/or with different pharmacologic modes of action should be tried.
• Termination of treatment
  • To be evaluated on a case‑by‑case basis
  • May be considered if the patient has < 2 seizures/year, an inconspicuous provocation EEG, normal psychological findings, and no hereditary predisposition
  • Generally possible after 2–5 seizure‑free years with normal EEG results
  • Medications must be tapered cautiously.

Nonpharmacological therapy

• Indications: pharmacoresistance
• Surgery
  • Prerequisite: epilepsy that does not respond to medications → often epilepsies with structural origin (most commonly temporal lobe epilepsy)
  • Procedures
    • Resection (surgical removal of pathological lesions)
      • Resection of the anteromedial temporal lobe or of the amygdala and the hippocampus → in patients with temporal lobe epilepsy
      • Resection of an entire hemisphere (hemispherectomy) → in patients with severe intractable seizures due to structural cerebral abnormalities confined to one hemisphere
    • Disconnection (surgical breaking of neuronal circuits)
• Stimulation techniques: vagus nerve stimulation, deep brain stimulation
• Dietary measures: ketogenic diet

It is necessary to distinguish between focal and primary generalized seizures in order to decide on the appropriate therapy!

References:^{[7][11][12][19][20][21][22]}

Status epilepticus

Criteria

• ≥ 5 min of continuous seizures
• OR ≥ 2 seizures with consciousness not being fully regained in the interictal period

Etiology

• Common causes are withdrawal from antiepileptic drugs; , metabolic disturbances; (e.g., hyponatremia), drug toxicity; (e.g., tricyclic antidepressants), structural brain lesions/injury (e.g., tumors, trauma, stroke), and CNS infections.

Treatment

1. Initial assessment and supportive treatment:
   • Place patient in recovery position to prevent injury.
   • Quick neurological examination (to determine type and cause of status epilepticus) and general medical evaluation (particularly airway, breathing, and circulation)
   • Establish secure IV access (two, if possible), collection of blood for routine blood tests (particularly electrolytes and glucose levels), toxicology screen, antiepileptic drug levels, and arterial blood gas (ABG) analysis
   • Supportive therapy as necessary (e.g., oxygen, glucose, thiamine naloxone )
   • Monitoring of vital signs: especially oxygen saturation (via pulse oximetry), blood pressure, cardiac action, and breathing
   • If patient does not regain consciousness after seizures stop or nonconvulsive status epilepticus is suspected → continuous EEG monitoring
   • If acute brain injury (e.g., intracerebral hemorrhage) is suspected → obtain a cranial CT
   • If CNS infection is suspected → conduct a lumbar puncture
2. Pharmacological interruption of seizures: initial treatment
   • First line: IV lorazepam; second line: IV diazepam or midazolam → if IV access is not possible or drugs are administered by someone who is not a medical professional → select another application form (e.g., rectal diazepam, buccal or intranasal lorazepam/midazolam)
     • If the patient does not respond within 1 minute → administer additional lorazepam (or a second-line benzodiazepine)
     • If the patient does not respond within another 10–20 minutes → saturation with fosphenytoin via separate access (alternatively: phenobarbital, levetiracetam, or valproate)
     • If seizure activity does not stop despite application of a benzodiazepine and a nonbenzodiazepine antiseizure drug → refractory status epilepticus
   • No later than 45–60 min after onset: continuous administration of anesthetics with intubation and ICU monitoring; e.g., thiopental, propofol, or midazolam
3. Nonbenzodiazepine therapy (to prevent recurrence): fosphenytoin or valproate

Prognosis

• Mortality of ∼ 20% (in adults with first occurrence of GCSE)

Status epilepticus is a life‑threatening event! If not interrupted, it can lead to cerebral edema, a dangerous rise in body temperature, rhabdomyolysis, and cerebral cardiovascular failure!

General complications of seizures and epilepsy

• Acute
  • Hyperthermia, cardiorespiratory deficits, excitatory toxicity → potentially irreversible tissue damage; (particularly to the CNS; , for example in the form of cortical laminar necrosis), which in turn may also result in further seizures
  • Postictal transient anion gap metabolic acidosis with increased lactic acid and reduced serum bicarbonate → usually resolves spontaneously within 60–90 minutes after seizure activity stops
  • Physical trauma (e.g., posterior dislocation of the glenohumeral joint)
• Long‑term
  • Associated psychiatric disorders (e.g., anxiety, depression and risk of suicide, cognitive impairments)
  • Psychosocial issues (e.g., problems at the workplace)

References:^{[11][12][20][23][24][25]}

We list the most important complications. The selection is not exhaustive.

Risk of seizure recurrence

• Overall risk of recurrence
  • After the first unprovoked seizure (within 2 years): ∼ 40%
  • After the second unprovoked seizure (within 1 year): ∼ 60%
• After a single tonic‑clonic seizure: ∼ 40%
• In genetic epilepsy: ∼ 25–30% (within 3 months)
• Patients with normal EEG results: ∼ 15% (within 1 year)
• Patients with abnormal EEG results: ∼ 40% (within 1 year)

Impact of medical therapy

• Immediate initiation of pharmacotherapy after a first unprovoked seizure lowers risk of recurrence in the short term (within 2 years) but does not significantly improve long‑term risk.
• Approx. 80% of epilepsy patients who are treated with antiepileptic drugs remain seizure‑free for extended periods (3–5 years).

References:^{[12][26][27][28][29]}

1. Seizure Disorders. http://www.merckmanuals.com/professional/neurologic-disorders/seizure-disorders/seizure-disorders. Updated: June 1, 2016. Accessed: March 29, 2017.
2. About Epilepsy: The Basics. http://www.epilepsy.com/learn/about-epilepsy-basics. Updated: March 1, 2014. Accessed: March 31, 2017.
3. A Revised Definition of Epilepsy. http://www.epilepsy.com/article/2014/4/revised-definition-epilepsy. Updated: April 1, 2014. Accessed: March 31, 2017.
4. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014; 55 (4): p.475-482. doi: 10.1111/epi.12550 . | Open in Read by QxMD
5. Types of Epilepsy Syndromes. http://www.epilepsy.com/learn/types-epilepsy-syndromes. Updated: September 1, 2013. Accessed: March 31, 2017.
6. Ko DY. Epilepsy and Seizures. Epilepsy and Seizures. New York, NY: WebMD. http://emedicine.medscape.com/article/1184846-overview. Updated: July 12, 2016. Accessed: March 31, 2017.
7. Le T, Bhushan V, Chen V, King M. First Aid for the USMLE Step 2 CK. McGraw-Hill Education ; 2015
8. Berg AT, Berkovic SF, Brodie MJ et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010; 51 (4): p.676-685. doi: 10.1111/j.1528-1167.2010.02522.x . | Open in Read by QxMD
9. Korff CM, Wirrell E. ILAE classification of seizures and epilepsy. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/ilae-classification-of-seizures-and-epilepsy?source=see_link.Last updated: October 20, 2015. Accessed: March 29, 2017.
10. Millichap JJ. Clinical Features and Evaluation of Febrile Seizures. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-features-and-evaluation-of-febrile-seizures.Last updated: March 3, 2017. Accessed: March 29, 2017.
11. Kasper DL, Fauci AS, Hauser SL, Longo DL, Lameson JL, Loscalzo J. Harrison's Principles of Internal Medicine. McGraw-Hill Education ; 2015
12. Agabegi SS, Agabegi ED. Step-Up To Medicine. Wolters Kluwer Health ; 2015
13. Wong ET, Wu JK. Clinical presentation and diagnosis of brain tumors. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-brain-tumors?source=search_result&search=brain%20tumor&selectedTitle=1~150#H4.Last updated: February 16, 2016. Accessed: February 19, 2017.
14. Misra UK, Kalita J. Management of provoked seizure. Ann Indian Acad Neurol. 2011; 14 (1): p.2-8. doi: 10.4103/0972-2327.78041 . | Open in Read by QxMD
15. Schachter SC. Evaluation and management of the first seizure in adults . In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/evaluation-and-management-of-the-first-seizure-in-adults.Last updated: February 21, 2017. Accessed: March 31, 2017.
16. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010; 51 (4): p.676-685. doi: 10.1111/j.1528-1167.2010.02522.x. . | Open in Read by QxMD
17. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr.. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001; 42 (9): p.1212-1218. doi: 10.1046/j.1528-1157.2001.22001.x . | Open in Read by QxMD
18. Ko DY. Generalized Tonic-Clonic Seizures. Generalized Tonic-Clonic Seizures. New York, NY: WebMD. http://emedicine.medscape.com/article/1184608-overview. Updated: June 30, 2015. Accessed: March 31, 2017.
19. Wilfong A. Seizures and epilepsy in children: Initial treatment and monitoring. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/seizures-and-epilepsy-in-children-initial-treatment-and-monitoring.Last updated: August 26, 2016. Accessed: March 31, 2017.
20. Schachter SC. Overview of the management of epilepsy in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/overview-of-the-management-of-epilepsy-in-adults.Last updated: March 1, 2017. Accessed: March 31, 2017.
21. Kossoff EH. The ketogenic diet and other dietary therapies for the treatment of epilepsy. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/the-ketogenic-diet-and-other-dietary-therapies-for-the-treatment-of-epilepsy.Last updated: May 4, 2016. Accessed: March 31, 2017.
22. The Organization of the Epilepsies: Report of the ILAE Commission on Classification and Terminology.
23. Drislane FW. Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/convulsive-status-epilepticus-in-adults-classification-clinical-features-and-diagnosis.Last updated: March 17, 2017. Accessed: March 31, 2017.
24. Drislane FW. Convulsive status epilepticus in adults: Treatment and prognosis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. http://www.uptodate.com/contents/convulsive-status-epilepticus-in-adults-treatment-and-prognosis.Last updated: March 3, 2017. Accessed: March 31, 2017.
25. Tonic Clonic (Grand Mal). http://www.medbullets.com/step2-3-neurology/20297/tonic-clonic-grand-mal. Updated: September 20, 2016. Accessed: March 31, 2017.
26. The prognosis of epilepsy.
27. Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008; 49 (Suppl 1): p.13-18. doi: 10.1111/j.1528-1167.2008.01444.x . | Open in Read by QxMD
28. Krumholz A, Shinnar S, French J, Gronseth G, Wiebe S. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology. 2015; 85 (17): p.1526-1527. doi: 10.1212/01.wnl.0000473351.32413.7c . | Open in Read by QxMD
29. Das CP, Sawhney IM, Lal V, Prabhakar S. Risk of recurrence of seizures following single unprovoked idiopathic seizure. Neurol India. 2000; 48 (4): p.357-360.